Sources | Names Used |
---|---|
CTRPv2 | selumetinib:piperlongumine (8:1 mol/mol) |
PharmacoGx | selumetinib:piperlongumine (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | COL6A3 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.009 |
mRNA | ARHGAP8 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.009 |
mRNA | CEACAM18 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.009 |
mRNA | SIGLEC7 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.009 |
mRNA | MLYCD | CTRPv2 | pan-cancer | AAC | 0.093 | 0.009 |
mRNA | PTK6 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.009 |
mRNA | AKR1B1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.009 |
mRNA | TPM4 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.009 |
mRNA | CNN1 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.009 |
mRNA | ADIG | CTRPv2 | pan-cancer | AAC | 0.089 | 0.009 |